AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Evaluation of Adding Nitrate Into Foods for Regulating Nitric Oxide Bioavailability in Healthy Individuals

RecruitingNAAges 18 Years - 60 YearsAllQueen Mary University of London
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Inorganic nitrate, found in leafy green vegetables and beetroot, can help lower blood pressure and support heart health. Early experimental work has suggested that dietary nitrate supplementation, in the form of beetroot juice or potassium nitrate capsules, can reduce blood pressure and improve endothelial function. Consequently, concentrated nitrate supplements like beetroot juice have become popular. However, these supplements can be expensive, high in sugar, and not to everyone's taste. Since more than three-quarters of adults with high blood pressure live in low- and middle-income countries, it is important to find safe, affordable ways to add nitrate to commonly eaten foods. The team at Queen Mary University of London has been developing nitrate-fortified products that may be more appealing to a wider population. With support from the food manufacturer Reading Scientific Services L

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Healthy volunteer. 2. Aged โ‰ฅ18 years and โ‰ค 60 years. 3. Willing to provide informed consent. 4. Able to understand and comply with protocol requirements, instructions, and stated restrictions. Exclusion Criteria: A volunteer will not be eligible for inclusion in this study if any of the following criteria are met: 1. Unwilling to provide consent. 2. People with chronic health conditions requiring medication. 3. Pregnant females, or those with a possibility of being pregnant. 4. History of hypertension and /or diabetes. 5. History of any serious illnesses, including recent infections or trauma. 6. History of symptomatic coronary artery disease, stroke, or other known atherosclerotic diseases. 7. People who will commence or who are likely to commence treatment with non-steroidal anti-inflammatory drugs (NSAIDs) other than aspirin, from screening until study completion. 8. Self-declared alcohol or drug abuse within the past 6 months. 9. Three-month prior history of regular alcohol consumption exceeding an average weekly intake of \> 28 units (or an average daily intake of greater than 3 units) for males, or an average weekly intake of \> 21 units (or an average daily intake of greater than 2 units) for females. One unit is equivalent to a half pint (284mL) of beer/lager; 25mL of spirits, or 125mL of wine. 10. Taking systemic medication (other than the oral contraceptive pill). 11. Recent (within 2 weeks) self-reported use of mouthwash or tongue scrapers. 12. Recent (within 2 weeks) or current antibiotic use. 13. Recent (within 1 week) use of NO3- or NO2- supplements. 14. History, or recent treatment of (within the last 3 months) for any oral condition (excluding caries), including gingivitis, periodontitis and halitosis. 15. History of, or recent treatment for, any blood-borne infectious disease such Hepatitis B or C virus, or HIV. 16. Current smokers (including vaping) or have smoked within the last 6 months. 17. Diagnosis of rheumatoid arthritis, connective tissue disorders, and other conditions known to be associated with chronic inflammation (e.g., Inflammatory Bowel Disease). 18. People who have donated more than 500mL of blood within 56 days prior to the study commencement. 19. Known allergy to celery, gluten, crustaceans, eggs, lupin, milk, mustard, peanuts, sesame, soybeans, tree nuts, oats, palm oil, sugar, cranberries, sunflower oil, invert syrup, sodium bicarbonate.
๐Ÿ’Š

What it tests

  • Inorganic potassium nitrate-fortified biscuits supplementation
  • Inorganic potassium nitrate-fortified cereal bar supplementation
  • Inorganic potassium nitrate-fortified porridge supplementation
๐Ÿ“

Where

1 site
The William Harvey Research Institute, Centre for Cardiovascular Medicines and Devices, Queen Mary University of London
London, United Kingdom
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy